These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17192765)

  • 21. Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model.
    Schilling G; Coonfield ML; Ross CA; Borchelt DR
    Neurosci Lett; 2001 Nov; 315(3):149-53. PubMed ID: 11716985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of coenzyme Q10 in heart failure.
    Weant KA; Smith KM
    Ann Pharmacother; 2005 Sep; 39(9):1522-6. PubMed ID: 16046484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease.
    Beal MF; Shults CW
    Biofactors; 2003; 18(1-4):153-61. PubMed ID: 14695931
    [No Abstract]   [Full Text] [Related]  

  • 24. [Coenzyme Q10: its biosynthesis and biological significance in animal organisms and in humans].
    Siemieniuk E; Skrzydlewska E
    Postepy Hig Med Dosw (Online); 2005; 59():150-9. PubMed ID: 15928598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coenzyme Q10 a mitochondrial restorer for various brain disorders.
    Pradhan N; Singh C; Singh A
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2197-2222. PubMed ID: 34596729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson's disease in experimental animals.
    Attia HN; Maklad YA
    Behav Pharmacol; 2018 Feb; 29(1):79-86. PubMed ID: 28902670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice.
    Stack EC; Smith KM; Ryu H; Cormier K; Chen M; Hagerty SW; Del Signore SJ; Cudkowicz ME; Friedlander RM; Ferrante RJ
    Biochim Biophys Acta; 2006 Mar; 1762(3):373-80. PubMed ID: 16364609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-enzyme Q10 to treat neurological disorders: basic mechanisms, clinical outcomes, and future research direction.
    Salama M; Yuan TF; Machado S; Murillo-Rodríguez E; Vega JA; Menéndez-González M; Nardi AE; Arias-Carrión O
    CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):641-64. PubMed ID: 23574157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Q10 therapy in patients with idiopathic Parkinson's disease.
    Strijks E; Kremer HP; Horstink MW
    Mol Aspects Med; 1997; 18 Suppl():S237-40. PubMed ID: 9266528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coenzyme Q10 serum levels in Huntington's disease.
    Andrich J; Saft C; Gerlach M; Schneider B; Arz A; Kuhn W; Müller T
    J Neural Transm Suppl; 2004; (68):111-6. PubMed ID: 15354396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP;
    JACC Heart Fail; 2014 Dec; 2(6):641-9. PubMed ID: 25282031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10.
    McCarthy S; Somayajulu M; Sikorska M; Borowy-Borowski H; Pandey S
    Toxicol Appl Pharmacol; 2004 Nov; 201(1):21-31. PubMed ID: 15519605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.
    Muthukumaran K; Kanwar A; Vegh C; Marginean A; Elliott A; Guilbeault N; Badour A; Sikorska M; Cohen J; Pandey S
    J Alzheimers Dis; 2018; 61(1):221-236. PubMed ID: 29154270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of Oxidative Damage by Coenzyme Q
    Gupta BK; Kumar S; Kaur H; Ali J; Baboota S
    Rejuvenation Res; 2018 Jun; 21(3):232-248. PubMed ID: 28844183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coenzyme Q10 supplementation in traumatic brain injury: a scoping review protocol.
    Allan K; Hayes K; Thomas M; Barnard K
    JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1901-1908. PubMed ID: 31145191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.
    Cleren C; Yang L; Lorenzo B; Calingasan NY; Schomer A; Sireci A; Wille EJ; Beal MF
    J Neurochem; 2008 Mar; 104(6):1613-21. PubMed ID: 17973981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10.
    Sharma SK; El Refaey H; Ebadi M
    Brain Res Bull; 2006 Jun; 70(1):22-32. PubMed ID: 16750479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: a systematic review.
    Roffe L; Schmidt K; Ernst E
    J Clin Oncol; 2004 Nov; 22(21):4418-24. PubMed ID: 15514384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic roles of coenzyme Q10 in peripheral nerve injury-induced neurosensory disturbances: Mechanistic insights from injury to recovery.
    Vachirarojpisan T; Srivichit B; Vaseenon S; Powcharoen W; Imerb N
    Nutr Res; 2024 Sep; 129():55-67. PubMed ID: 39217889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered redox state of platelet coenzyme Q10 in Parkinson's disease.
    Götz ME; Gerstner A; Harth R; Dirr A; Janetzky B; Kuhn W; Riederer P; Gerlach M
    J Neural Transm (Vienna); 2000; 107(1):41-8. PubMed ID: 10809402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.